BioPharmX Corporation (OTCQB: BPMX) today announced the availability of Violet™ iodine, a new, once-daily pill for relief of premenstrual breast discomfort. The first-of-its-kind product is based on the latest molecular iodine technology designed to help free women from the burden of breast discomfort by addressing the underlying causes of a condition known as fibrocystic breast condition (FBC), with the added benefit of promoting breast health for women of reproductive age.*
*These statements have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7378951-biopharmx-introducing-violet-iodine-premenstrual-breast-discomfort/
http://icostumescheap.com Gives you great costume, party supplies,and party decorations video reviews are here for you. You can watch funny, talented costumes ideas that will make you the hit at the party or on your trick or treat rounds. Don't forget to check out old and new costume videos.
Are you someone who sweats all of the time? Have you tried just about every remedy you can think of and it still isn't getting any better? If so, this article will tell you how to stop sweating naturally. It can be very embarrassing when people appear to treat you as if you are unhygienic even though you know that you have showered at least twice that day and, to top it all off, if your self-esteem wasn't already low enough; the way in which others treat you can make it even worse.
We had a great solution for your problem!!!
Please visit us on http://www.howtostopsweatingnaturally.net and http://www.howtostopsweatingnaturally.net/stop-excessive-sweating-naturally
Spotted: Nick Offerman and his dad Ric fishing in a handmade canoe on a serene and quiet lake, communicating as only fathers and sons do.
Of the experience, Offerman said, “Working with my Dad (aka my hero) was a sincere honor and a treat - especially since all we had to do was go fishing. And if people have enjoyed my stoic expressions, then I expect they’re about to have their hats fly off when they lay eyes on the face of the august edifice from whence I sprung.”
Grab your dad, pour yourselves a glass of Lagavulin and enjoy responsibly.
To view the multimedia release go to:
http://www.multivu.com/players/English/7848951-my-tales-of-whisky-fathers-day/
Abbott today announced the U.S. Food and Drug Administration (FDA) approved the Masters HP™ 15mm rotatable mechanical heart valve, the world’s smallest mechanical heart valve, that will allow doctors to treat babies and toddlers in need of a mitral or aortic valve replacement. Until today, surgeons could only use a range of larger-sized valves to replace a pediatric heart valve that could not be repaired, and larger valves are often not suitable given the smaller size of children’s hearts. This dime-sized new valve is the first and only pediatric mechanical heart valve developed for newborns and infants, and offers hope for pediatric patients in urgent need of treatment who have no other approved options.
To view the multimedia release go to:
https://www.multivu.com/players/English/8280551-abbott-pediatric-heart-valve-fda-approval/
Children’s Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53686-cord-blood-childrens-memorial-hermann-fda-approved-stem-cells-hearing-loss
See http://www.strategicdc.com/18102 for more details or contact us at info@strategicdc.com
We are looking to find an energetic, enthusiastic FT Associate to join our team. We have 3 clinics located in the beautiful La Crosse, WI area. We are looking for someone with a passion for chiropractic and someone who cares for the individual patient. While we treat a wide variety of musculoskeletal injuries, we focus on patient centered care. We look forward to hearing from you.
https://thetruthaboutketosis.com/
The Ketogenic diet or Keto Diet is not a diet fad or a new diet. Although over the last few years the Keto Diet has received a lot of attention, both positive and negative, the Keto Diet has been around for almost one hundred years.
Keto was created by doctors in 1924 to treat epilepsy, and more recently has been studied as a treatment for diabetes.
Keto really works and has unbelievable health benefits, besides weight loss, that you will notice in a short period of time.
During a live global event, Elekta announced the launch of Versa HD™, an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of cancers. Featuring high precision beam shaping and tumor targeting, Versa HD also unveils new capabilities designed to maximize health care system resources and deliver highly sophisticated therapies without compromising treatment times.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60246-elekta-sets-new-benchmark-for-cancer-treatment-launch-of-versa-hd-system
Dunkin’ Donuts® packaged coffee is celebrating the holidays with a new Gingerbread Cookie variety! Jump into the season with a big mug of delicious Dunkin’ Donuts coffee at home with friends and family. Other holiday varieties include Pumpkin Spice and Mocha Mint. Complementing its whimsical packaging, select bags of Dunkin’ Donuts seasonal coffees include a paper gift tag, making it the perfect stocking stuffer, hostess gift or holiday treat.
To view Multimedia News Release, go to http://www.multivu.com/players/English/58313-dunkin-donuts-seasonal-coffees-holiday-gift-giving/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
